Roth Capital lowered the firm’s price target on Dorman Products (DORM) to $162 from $182 and keeps a Buy rating on the shares. The company reported better than expected Q4 results but lower than expected FY26 guidance, the analyst tells investors in a research note. Light Duty demand continues to be robust, while Heavy Duty seems to have turned the corner and Specialty remains steady, the firm added.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DORM:
- Dorman Products upgraded to Buy from Hold at Jefferies
- Dorman Products price target lowered to $150 from $180-$190 at Barrington
- Dorman Products reports Q4 adjusted EPS $2.17, consensus $2.12
- Dorman Products sees FY26 adjusted EPS $8.10-$8.50, consensus $9.44
- DORM Earnings Report this Week: Is It a Buy, Ahead of Earnings?